Insight Guru Inc.
09/04/2026 | Press release | Distributed by Public on 09/04/2026 04:21
18 Mid Cap Stocks Just Made New 52-Week Highs
A new list of market highs raises an old question about the businesses earning those prices.
By industry, today's list is led by Biotechnology with 3 names, followed by Life & Health Insurance and Reinsurance, each with 2 names. As of Thursday, September 3, 18 Mid Cap stocks with a market value above $10 billion are trading at their 52-week highs.
The largest company on the list is Biogen (BIIB), with a market value of about $33.2 billion. Yet the sharpest recent gain belongs to Paycom Software (PAYC), up 37.8% over the last month. This raises the essential question for any 52-week-high screen: is the business performance justifying the price?
The 10 Largest, By Market Cap
The table below shows the 10 largest of the 18 names, sorted by market capitalization, with returns over four windows:
| Tickers |
Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| BIIB | $33.16 Bil | 0.8% | 1.4% | 8.7% | 58.5% |
| FTI | $31.73 Bil | 0.5% | 4.9% | 15.7% | 110.0% |
| PFG | $25.59 Bil | 7.3% | 6.5% | 4.0% | 54.4% |
| DINO | $19.05 Bil | 0.1% | 9.4% | 28.7% | 112.6% |
| GEN | $18.77 Bil | 2.2% | 2.7% | 12.6% | 7.7% |
| CNH | $17.13 Bil | 1.4% | 21.1% | 28.3% | 24.5% |
| RGA | $16.63 Bil | 1.4% | 4.0% | 8.7% | 32.5% |
| SOLV | $15.96 Bil | 0.6% | 1.7% | 5.7% | 29.5% |
| CRBG | $15.78 Bil | 3.6% | 6.5% | 3.5% | 4.7% |
| UNM | $15.42 Bil | 4.1% | 4.5% | 8.4% | 35.9% |
A new high can reflect very different growth stories.
Consider two names from the list. Gen Digital (GEN) saw its revenue grow 20.2% over the last twelve months, with an operating margin of 42.8%. In contrast, Biogen (BIIB) is trading at 39.7 times trailing earnings (on trailing earnings that include at least one loss quarter, so the multiple is not comparable to a clean-year multiple). Its revenue grew 0.3% over the last twelve months, and its operating margin is 19.3%.
A high price is a question, not an answer.
Strength can persist, and stocks making new highs often continue to do so. But a price is just a price. It is not a verdict on a company's quality or a guarantee of future returns. The disciplined move is to treat a 52-week high as a starting point for research. The real work is checking whether the business fundamentals can earn the level the market has set.
A new high tells you what the market already believes. The harder question is which of these runs management itself is underwriting. Our Guidance Momentum screen tracks exactly that: stocks where the company raised its own forward numbers.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the three major indices - the S&P 500, S&P Mid-cap, and Russell 2000. Use the high list for ideas; use the portfolio for the compounding.
Insight Guru Inc. published this content on September 04, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 04, 2026 at 10:21 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]